October 23-24, 2015
Course Directors: Ramesh K. Ramanathan, M.D., Mitesh J. Borad, M.D. and Daniel D. Von Hoff, M.D.
This course, offered in cooperation with TGEN and Honor Health, welcomes expert faculty from across the country and throughout Mayo Clinic to bring you a state-of-the-art conference with the latest treatment options. The program is designed to provide a multi-disciplinary overview regarding the molecular biology of pancreatic cancer and the importance of early diagnosis and treatment considerations, including surgery, new pharmacological agents, and how to incorporate these into clinical practice.
Registration Fee
Online Fee Before 10/7/2015 | Standard Fee | |
Physicians active in practice | $300 | $375 |
Other: Resident, retired and allied health | $225 | $300 |
Course Credit
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been accredited by the American Osteopathic Association for 10.0 credits of AOA Category 2-A.
Course Objectives
- Identify patients who will benefit from radiation therapy
- Incorporate novel agents in clinical care and clinical trial participation
- Explain palliative care management of the symptomatic patient
- Describe molecular biology of pancreatic cancer
- Describe the role of the PARP inhibitors and DNA damaging agents in the treatment of pancreatic cancer
- Select the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer
- Describe the differences in staging between borderline and unresectable locally advanced pancreatic cancer
- Identify patients with resecetable pancreatic cancer who are candidates for a minimally invasive procedure
- Explain the role of proton therapy and potential uses in pancreatic cancer
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Exhibit Opportunity
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Kristy Badder .